Log in to your Inderes Free account to see all free content on this page.
Fluicell
0.033
SEK
-19.9 %
FLUI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
4 following
-19.9%
-43.3%
-57.91%
-63.25%
-77.55%
-82.28%
-99.24%
-98.22%
-98.96%
Fluicell is a biotechnology company. The company conducts research and development in processing the composition of cells in the development of new pharmaceuticals. The company has developed a product portfolio consisting of patented research instruments, which are used to study, analyze and finally process cells. In addition, there is expertise in 2D / 3D printing. Fluicell was founded in 2012 and is headquartered in Gothenburg.
Read moreMarket cap
15.87M SEK
Turnover
411.63K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
7.3.
2025
Annual report '24
9.5.
2025
Interim report Q1'25
14.5.
2025
General meeting '24
ShowingAll content types
BioStock: 2021 represents beginning of new era for Fluicell
BioStock: Fluicell dives into regenerative medicine field
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio